Stock Market Today: GIFT Nifty indicates a flat start; Sun Pharma to acquire nearly Rs 28.69 cr stake in Ezerx Health Tech

Stock Market Today

Stock Market Today: The NSE IX’s GIFT Nifty traded 4 points, higher at 19609, indicating that Dalal Street was likely to get off to a slow start on Friday. As investors awaited important US jobs data, Tokyo markets opened lower on Friday, mirroring minor losses on Wall Street.The larger Topix index fell 0.07 percent, or 1.62 points, to 2,262.14, while the benchmark Nikkei 225 index was down 0.11 percent, or 35.01 points, at 31,040.35 in early trade.

Dollar dipped; Wall Street ended up lower

The dollar fell on Friday, but traders mainly avoided the currency and U.S. Treasury markets as they waited for potential triggers in the release of U.S. nonfarm payrolls data later in the day. After recovering from session lows on Thursday, U.S. equities ended marginally lower as investors awaited Friday’s monthly jobs data and any potential cues regarding the direction of interest rates. The benchmark 30-share BSE Sensex increased 405 points or 0.62% to close at 65,631. The more inclusive NSE Nifty increased 110 points or 0.56% to close at 19,546.

Stock Market Today: Sun Pharma to acquire nearly Rs 28.69 cr stake in Ezerx Health Tech

The world’s largest pharmaceutical company Sun Pharma said on October 5 that it will pay Rs 28.69 crore to purchase a share of about 37.76 percent in Ezerx Health Tech. A manufacturer of ancillary and non-invasive medical devices, EzeRx. Sun Pharma stated in a regulatory filing that the business will also pay Rs 4.5 crore for an additional 4 percent stake in Agatsa Software Private Limited, bringing its overall stake in the company to 30.13 percent after all tranches are closed.

Disclaimer: (This information is provided solely for informational purposes. It is important to note that investing in the market or a business idea involves market risks. Before investing money as an investor/ owner/ partner, always consult an expert. DNP News Network Private Limited never advises to invest money on stocks or any specific business idea. We will not be liable for any financial losses.)

Also Read: OPPO F21s Pro VS OPPO F21 PRO: Specifications, features and price compared to facilitate decision making

Keep watching our YouTube Channel ‘DNP INDIA’. Also, please subscribe and follow us on FACEBOOKINSTAGRAM, and TWITTER

Exit mobile version